March 15, 2016
MedMined Surveillance Advisor named “the best technology for Infection Control and Monitoring”
MedMined Surveillance Advisor named “the best technology for Infection Control and Monitoring”
Pharmaceuticals, Biotechnology and Life Sciences
Category: news
March 15, 2016
FDA Approves ZEPATIER for the Treatment of Chronic Hepatitis C Infection
On January 28, 2016, the United States Food and Drug Administration (FDA) approved Zepatier (elbasvir and grazoprevir) for the treatment of chronic genotype 1 or 4 hepatitis C virus (HCV) infection in adults.
March 15, 2016
J&J’s research shows adults with Type 2 Diabetes get greater blood glucose control with Invokana (canagliflozin)
J&J has annonced that results of a new analysis of data from real-world clinical practice show that, in adults with type 2 diabetes
March 15, 2016
Decoding the molecular ties between vascular disease and Alzheimer’s
Scientists have long been interested in how the vascular system — the body’s network of large and small blood vessels — may be involved in the onset and progression of Alzheimer’s disease and related dementias.
March 15, 2016
Ethicon To Acquire NeuWave Medical
Ethicon, a medical device company of the Johnson & Johnson family of companies, has announced a definitive agreement to acquire NeuWave Medical, Inc., a privately held medical device company that manufactures and markets minimally invasive soft tissue microwave ablation systems.
March 15, 2016
Fish and insects guide design for future contact lenses
Making the most of the low light in the muddy rivers where it swims, the elephant nose fish survives…
March 14, 2016
Teva recalls amikacin sulfate injection USP lot
Teva Pharmaceuticals has announced a voluntary recall of one lot of amikacin sulfate injection USP, 1 gram/4mL (250 mg/mL) vials…
March 14, 2016
GW Pharmaceutical announces positive Phase 3 test results for Epidiolex (Dravet syndrome)
GW Pharmaceutical announces positive Phase 3 test results for Epidiolex (Dravet syndrome)
March 14, 2016
USPTO issues Notice of Allowance to Horizon Pharma for VIMOVO
United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance to Horizon Pharma for U.S. patent application number…
March 13, 2016
Sanofi and Regeneron in Phase 3 study shows sarilumab was superior to adalimumab for treating RA patients
Sanofi and Regeneron Pharmaceuticals, Inc. have announced that a Phase 3 monotherapy study met its primary endpoint demonstrating that sarilumab…